Stryker Corp. (SYK) financial statements: income statement, balance sheet and cash flow

Stryker Corp.'s income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Stryker Corp. reported revenue of $25.1B (+11.2% year on year) and net income of $3.2B (+8.5% year on year).

Income statement

Stryker Corp. income statement, fiscal years

Line item	Dec 31, 2025 · FY	Dec 31, 2024 · FY	Dec 31, 2023 · FY	Dec 31, 2022 · FY
Net sales	$25.1B	$22.6B	$20.5B	$18.4B
Cost of sales	$9.1B	$8.2B	$7.4B	$6.9B
Gross profit	$16.1B	$14.4B	$13.1B	$11.6B
Research, development and engineering expenses	$1.6B	$1.5B	$1.4B	$1.5B
Selling, general and administrative expenses	$8.7B	$7.7B	$7.1B	$6.5B
Amortization of intangible assets	$732.0M	$623.0M	$635.0M	$627.0M
Goodwill and other impairments	$170.0M	$977.0M	—	—
Total operating expenses	$11.2B	$10.8B	$9.2B	$8.7B
Operating income	$4.9B	$3.7B	$3.9B	$2.8B
Interest expense	($607.0M)	—	—	—
Other income	$232.0M	($197.0M)	($215.0M)	($158.0M)
Earnings before income taxes	$4.5B	$3.5B	$3.7B	$2.7B
Income taxes	$1.3B	$499.0M	$508.0M	$325.0M
Net earnings	$3.2B	$3.0B	$3.2B	$2.4B
Basic net earnings per share of common stock (in dollars per share)	$8.49	$7.86	$8.34	$6.23
Diluted net earnings per share of common stock (in dollars per share)	$8.40	$7.76	$8.25	$6.17
Basic (in shares)	382.2M	381.0M	379.6M	378.2M
Effect of dilutive employee stock compensation (in shares)	4.3M	4.6M	4.1M	4.0M
Diluted (in shares)	386.5M	385.6M	383.7M	382.2M

Stryker Corp. income statement, quarters

Line item	Jun 30, 2026 · Q2	Mar 31, 2026 · Q1	Sep 30, 2025 · Q3	Jun 30, 2025 · Q2
Net sales	$6.6B	$6.0B	$6.1B	$6.0B
Cost of sales	$2.1B	$2.2B	$2.2B	$2.2B
Gross profit	$4.5B	$3.8B	$3.9B	$3.8B
Research, development and engineering expenses	$434.0M	$413.0M	$410.0M	$407.0M
Selling, general and administrative expenses	$2.2B	$2.3B	$2.0B	$2.1B
Amortization of intangible assets	$175.0M	$180.0M	$189.0M	$187.0M
Asset impairments	$1.0M	$0	$73.0M	$55.0M
Total operating expenses	$2.8B	$2.9B	$2.7B	$2.7B
Operating income	$1.7B	$936.0M	$1.1B	$1.1B
Interest expense	($141.0M)	($148.0M)	—	—
Other income	$46.0M	$62.0M	($106.0M)	($97.0M)
Earnings before income taxes	$1.6B	$850.0M	$1.0B	$1.0B
Income taxes	$288.0M	$105.0M	$170.0M	$132.0M
Net earnings	$1.3B	$745.0M	$859.0M	$884.0M
Basic (in dollars per share)	$3.32	$1.95	$2.25	$2.32
Diluted (in dollars per share)	$3.30	$1.93	$2.22	$2.29
Basic (in shares)	383.5M	382.9M	382.4M	382.2M
Effect of dilutive employee stock compensation (in shares)	2.5M	3.6M	4.3M	4.2M
Diluted (in shares)	386.0M	386.5M	386.7M	386.4M
Cash dividends declared per share of common stock (in dollars per share)	$0.88	$0.88	$0.84	$0.84

Balance sheet

Stryker Corp. balance sheet, fiscal years

Line item	Dec 31, 2025 · FY	Dec 31, 2024 · FY	Dec 31, 2023 · FY	Dec 31, 2022 · FY
Cash and cash equivalents	$4.0B	$3.7B	$3.0B	$1.8B
Short-term investments	$0	$750.0M	—	—
Marketable securities	$89.0M	$91.0M	$82.0M	$84.0M
Accounts receivable, less allowance of $216 ($213 in 2024)	$4.0B	$4.0B	$3.8B	$3.6B
Materials and supplies	$1.3B	$1.1B	$1.2B	$1.0B
Work in process	$415.0M	$336.0M	$330.0M	$348.0M
Finished goods	$3.5B	$3.3B	$3.3B	$2.6B
Total inventories	$5.3B	$4.8B	$4.8B	$4.0B
Prepaid expenses and other current assets	$1.3B	$1.6B	$857.0M	$787.0M
Total current assets	$14.8B	$14.8B	$12.5B	$10.3B
Land, buildings and improvements	$1.8B	$1.6B	$1.7B	$1.7B
Machinery and equipment	$5.7B	$5.1B	$4.7B	$4.1B
Total property, plant and equipment	$7.5B	$6.7B	$6.3B	$5.8B
Less allowance for depreciation	$3.7B	$3.2B	$3.1B	$2.8B
Property, plant and equipment, net	$3.9B	$3.4B	$3.2B	$3.0B
Goodwill	$19.3B	$15.9B	$15.2B	$14.9B
Other intangibles, net	$5.7B	$4.4B	$4.6B	$4.9B
Noncurrent deferred income tax assets	$1.1B	$1.7B	$1.7B	$1.4B
Other noncurrent assets	$3.1B	$2.7B	$2.7B	$2.5B
Total assets	$47.8B	$43.0B	$39.9B	$36.9B
Accounts payable	$1.8B	$1.7B	$1.5B	$1.4B
Accrued compensation	$1.6B	$1.4B	$1.5B	$1.1B
Income taxes	$418.0M	$539.0M	$391.0M	$292.0M
Dividend payable	$337.0M	$320.0M	$304.0M	$284.0M
Accrued expenses and other liabilities	$2.6B	$2.3B	$1.9B	$1.7B
Current maturities of debt	$1.0B	$1.4B	$2.1B	$1.2B
Total current liabilities	$7.8B	$7.6B	$7.9B	$6.3B
Long-term debt, excluding current maturities	$14.9B	$12.2B	$10.9B	$11.9B
Income taxes	$402.0M	$349.0M	$567.0M	$641.0M
Other noncurrent liabilities	$2.4B	$2.2B	$1.9B	$1.5B
Total liabilities	$25.4B	$22.3B	$21.3B	$20.3B
Common stock, $0.10 par value	$38.0M	$38.0M	$38.0M	$38.0M
Additional paid-in capital	$2.6B	$2.4B	$2.2B	$2.0B
Retained earnings	$20.5B	$18.5B	$16.8B	$14.8B
Accumulated other comprehensive loss	($687.0M)	($293.0M)	($416.0M)	($221.0M)
Total shareholders' equity	$22.4B	$20.6B	$18.6B	$16.6B
Total liabilities & shareholders' equity	$47.8B	$43.0B	$39.9B	$36.9B
Common stock, par value (in dollars per share)	$0.10	$0.10	$0.10	$0.10

Stryker Corp. balance sheet, quarters

Line item	Jun 30, 2026	Mar 31, 2026	Sep 30, 2025	Jun 30, 2025
Cash and cash equivalents	$3.4B	$2.9B	$3.3B	$2.4B
Marketable securities	$85.0M	$87.0M	$87.0M	$89.0M
Accounts receivable, less allowance of $215 ($216 in 2025)	$3.7B	$3.6B	$3.6B	$3.9B
Materials and supplies	$1.4B	$1.5B	$1.4B	$1.3B
Work in process	$470.0M	$435.0M	$442.0M	$436.0M
Finished goods	$3.6B	$3.5B	$3.6B	$3.5B
Total inventories	$5.5B	$5.4B	$5.4B	$5.3B
Prepaid expenses and other current assets	$1.7B	$1.4B	$1.4B	$1.3B
Total current assets	$14.4B	$13.3B	$13.7B	$13.0B
Land, buildings and improvements	$1.8B	$1.8B	$1.8B	$1.7B
Machinery and equipment	$6.0B	$5.8B	$5.6B	$5.5B
Total property, plant and equipment	$7.8B	$7.6B	$7.4B	$7.3B
Less allowance for depreciation	$3.9B	$3.7B	$3.7B	$3.6B
Property, plant and equipment, net	$4.0B	$3.9B	$3.7B	$3.7B
Goodwill	$19.6B	$19.2B	$19.3B	$19.2B
Other intangibles, net	$5.7B	$5.5B	$5.8B	$6.0B
Noncurrent deferred income tax assets	$994.0M	$1.2B	$1.4B	$1.4B
Other noncurrent assets	$3.2B	$3.2B	$3.1B	$3.1B
Total assets	$47.9B	$46.3B	$47.1B	$46.3B
Accounts payable	$1.7B	$1.6B	$1.5B	$1.4B
Accrued compensation	$1.1B	$885.0M	$1.3B	$1.1B
Income taxes	$224.0M	$476.0M	$118.0M	$91.0M
Dividends payable	$338.0M	$337.0M	$321.0M	$321.0M
Accrued expenses and other liabilities	$2.6B	$2.5B	$2.4B	$2.6B
Current maturities of debt	$750.0M	$499.0M	$1.8B	$1.8B
Total current liabilities	$6.7B	$6.3B	$7.4B	$7.3B
Long-term debt, excluding current maturities	$14.2B	$14.2B	$14.8B	$14.8B
Income taxes	$406.0M	$403.0M	$400.0M	$395.0M
Other noncurrent liabilities	$2.7B	$2.4B	$2.6B	$2.6B
Total liabilities	$23.9B	$23.3B	$25.3B	$25.1B
Common stock, $0.10 par value	$38.0M	$38.0M	$38.0M	$38.0M
Additional paid-in capital	$2.7B	$2.6B	$2.6B	$2.5B
Retained earnings	$21.8B	$20.9B	$20.0B	$19.4B
Accumulated other comprehensive loss	($576.0M)	($583.0M)	($766.0M)	($762.0M)
Total shareholders' equity	$24.0B	$23.0B	$21.8B	$21.2B
Total liabilities and shareholders' equity	$47.9B	$46.3B	$47.1B	$46.3B

Cash flow statement

Stryker Corp. cash flow statement, fiscal years

Line item	Dec 31, 2025 · FY	Dec 31, 2024 · FY	Dec 31, 2023 · FY	Dec 31, 2022 · FY
Net earnings	$3.2B	$3.0B	$3.2B	$2.4B
Depreciation	$461.0M	$427.0M	$393.0M	$371.0M
Amortization of intangible assets	$732.0M	$623.0M	$635.0M	$627.0M
Goodwill and other impairments	$170.0M	$977.0M	—	—
Share-based compensation	$243.0M	$229.0M	$205.0M	$168.0M
Sale of inventory stepped up to fair value at acquisition	$173.0M	$46.0M	$0	$12.0M
Deferred income tax (benefit) expense	$392.0M	($370.0M)	($206.0M)	$58.0M
Accounts receivable	$127.0M	($321.0M)	($175.0M)	($579.0M)
Inventories	($297.0M)	($206.0M)	($797.0M)	($762.0M)
Accounts payable	$94.0M	$192.0M	$77.0M	$290.0M
Accrued expenses and other liabilities	$318.0M	$74.0M	$533.0M	$328.0M
Income taxes	($145.0M)	($116.0M)	($4.0M)	($238.0M)
Other, net	($470.0M)	($306.0M)	($134.0M)	($107.0M)
Net cash provided by operating activities	$5.0B	$4.2B	$3.7B	$2.6B
Acquisitions, net of cash acquired	($5.0B)	($1.6B)	($390.0M)	($2.6B)
Proceeds/(Purchases) of short-term investments	$750.0M	—	—	—
Purchases of property, plant and equipment	($761.0M)	($755.0M)	($575.0M)	($588.0M)
Proceeds from the sale of the Spinal Implants business	$165.0M	—	—	—
Other investing, net	($60.0M)	$43.0M	$1.0M	$39.0M
Net cash used in investing activities	($4.9B)	($3.0B)	($962.0M)	($2.9B)
Proceeds (payments) on short-term borrowings, net	$0	($32.0M)	$540.0M	($375.0M)
Proceeds from issuance of long-term debt	$3.0B	$3.0B	$1.2B	$1.5B
Payments on long-term debt	($1.4B)	($2.0B)	($2.1B)	($653.0M)
Payments of dividends	($1.3B)	($1.2B)	($1.1B)	($1.1B)
Cash paid for taxes from withheld shares	-149.0M	-195.0M	-155.0M	-122.0M
Other financing, net	($33.0M)	($51.0M)	($23.0M)	($48.0M)
Net cash provided by (used in) financing activities	$113.0M	($525.0M)	($1.6B)	($749.0M)
Effect of exchange rate changes on cash and cash equivalents	$68.0M	($36.0M)	($28.0M)	($51.0M)
Change in cash and cash equivalents	$359.0M	$681.0M	$1.1B	($1.1B)
Cash and cash equivalents at beginning of year	$3.7B	$3.0B	$1.8B	$2.9B
Cash and cash equivalents at end of year	$4.0B	$3.7B	$3.0B	$1.8B
Cash paid for income taxes, net of refunds	$1.0B	$989.0M	$693.0M	$505.0M
Cash paid for interest on debt	$582.0M	$396.0M	$356.0M	$324.0M

Stryker Corp. cash flow statement, quarters

Line item	Jun 30, 2026 · YTD	Mar 31, 2026 · Q1	Sep 30, 2025 · YTD	Jun 30, 2025 · YTD
Net earnings	$2.0B	$745.0M	$2.4B	$1.5B
Depreciation	$241.0M	$120.0M	$334.0M	$214.0M
Amortization of intangible assets	$355.0M	$180.0M	$543.0M	$354.0M
Asset impairments	$1.0M	$0	$163.0M	$90.0M
Share-based compensation	$141.0M	$87.0M	$195.0M	$133.0M
Sale of inventory stepped-up to fair value at acquisition	$0	$0	$160.0M	$99.0M
Deferred income tax (benefit) expense	$74.0M	($33.0M)	$191.0M	$176.0M
Accounts receivable	$267.0M	$444.0M	$524.0M	$257.0M
Inventories	($240.0M)	($127.0M)	($373.0M)	($226.0M)
Accounts payable	($127.0M)	($198.0M)	($205.0M)	($269.0M)
Accrued expenses and other liabilities	($356.0M)	($654.0M)	($78.0M)	($116.0M)
Income taxes	($258.0M)	$42.0M	($577.0M)	($610.0M)
Other, net	($277.0M)	($25.0M)	($373.0M)	($279.0M)
Net cash provided by operating activities	$1.8B	$581.0M	$2.9B	$1.4B
Acquisitions, net of cash acquired	($459.0M)	($22.0M)	($5.0B)	($4.8B)
Purchases of marketable securities	($19.0M)	($5.0M)	($32.0M)	($27.0M)
Proceeds/(Purchases) of short-term investments	$0	$0	$750.0M	—
Proceeds from sales of marketable securities	$23.0M	$7.0M	$40.0M	$32.0M
Purchases of property, plant and equipment	($368.0M)	($166.0M)	($493.0M)	($306.0M)
Proceeds from the sale of the Spinal Implants business	$0	—	$165.0M	$165.0M
Other investing, net	($1.0M)	$1.0M	($41.0M)	($40.0M)
Net cash used in investing activities	($824.0M)	($185.0M)	($4.6B)	($4.2B)
Proceeds (payments) on short-term borrowings, net	$250.0M	—	$1.0M	$2.0M
Proceeds from issuance of long-term debt	$0	$0	$3.0B	$3.0B
Payments on long-term debt	($1.0B)	($1.0B)	($650.0M)	($650.0M)
Payments of dividends	($674.0M)	($337.0M)	($963.0M)	($641.0M)
Cash paid for taxes from withheld shares	-146.0M	-139.0M	-132.0M	-115.0M
Other financing, net	($35.0M)	($34.0M)	($29.0M)	($30.0M)
Net cash provided by (used in) financing activities	($1.6B)	($1.5B)	$1.2B	$1.5B
Effect of exchange rate changes on cash and cash equivalents	($33.0M)	($19.0M)	$58.0M	$57.0M
Change in cash and cash equivalents	($620.0M)	($1.1B)	($396.0M)	($1.3B)
Cash and cash equivalents at beginning of period	$4.0B	$4.0B	$3.7B	$3.7B
Cash and cash equivalents at end of period	$3.4B	$2.9B	$3.3B	$2.4B

Stryker Corp. score and earnings-call analysis · All covered companies

Figures as reported in SEC filings. General information, not investment advice.